epigallocatechin gallate has been researched along with Injury, Myocardial Reperfusion in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 5 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Liu, P; Mei, W; Wang, C; Wen, C; Xu, J; Zeng, X | 1 |
| Chen, JX; He, YL; Lin, WT; Wei, X; Xu, WX; Zeng, M | 1 |
| Ge, J; Kong, J; Li, Y; Ma, K | 1 |
| Guo, QH; Liu, JJ; Liu, Y; Wei, XY; Yin, N; Zeng, WJ; Zeng, YF | 1 |
| Chen, L; Gan, X; Jian, J; Liang, R; Yang, X; Zhang, C | 1 |
| He, H; He, S; Jiang, Q; Jiao, Y; Tu, Q; Xu, M; Zheng, W | 1 |
| Chen, ZZ; Dou, J; Lei, SQ; Leng, Y; Meng, QT; Wu, Y; Xia, ZY; Zhao, B; Zhu, J | 1 |
| Fan, KJ; Gu, J; Hu, J; Liang, HM; Qin, CY; Shen, JY; Xiao, ZH; Xu, F; Zhang, EY; Zhang, HW | 1 |
| Dähnert, I; Dhein, S; Salameh, A; Schuster, R; Seeger, J | 1 |
| Geng, Y; Huang, M; Nan, C; Nan, J; Qian, L; Rahman, MSU; Xing, D; Ye, J | 1 |
| Jian, J; Liang, R; Liao, P; Zhang, C; Zheng, X | 1 |
| Bae, HB; Heo, BH; Jeong, CW; Kim, SJ; Kwak, SH; Lee, HJ; Lee, SH; Li, M; Yoo, KY; Yook, KB | 1 |
| Jian, J; Xuan, F | 1 |
| Fan, KJ; Gu, J; Hu, J; Qin, CY; Xiao, Z; Xu, F; Zhang, EY; Zhang, HW | 1 |
| Hyon, SH; Ikeda, T; Marui, A; Matsumura, K; Morishima, M; Sakata, R; Yanagi, S | 1 |
| Akhlaghi, M; Bandy, B | 1 |
| Chiba, T; Fukuzawa, Y; Hirai, M; Hotta, Y; Ishikawa, N; Isobe, F; Kawamura, N; Nakano, A; Wakida, Y | 1 |
| Colantuono, G; Federici, A; Kim, JA; Marasciulo, FL; Montagnani, M; Potenza, MA; Quon, MJ; Tarquinio, M; Tiravanti, E | 1 |
1 review(s) available for epigallocatechin gallate and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies.
Topics: Animals; Animals, Laboratory; Catechin; Myocardial Infarction; Myocardial Reperfusion Injury | 2023 |
17 other study(ies) available for epigallocatechin gallate and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Epigallocatechin-3-gallate protects cardiomyocytes from hypoxia-reoxygenation damage via raising autophagy related 4C expression.
Topics: Apoptosis; Autophagy-Related Proteins; Catechin; Cell Hypoxia; Cell Line; Cysteine Endopeptidases; Gene Expression Regulation, Enzymologic; Humans; Myocardial Reperfusion Injury; Myocytes, Cardiac | 2021 |
EGCG protects against myocardial I/RI by regulating lncRNA Gm4419-mediated epigenetic silencing of the DUSP5/ERK1/2 axis.
Topics: Animals; Autophagy; Catechin; Cells, Cultured; Disease Models, Animal; Dual-Specificity Phosphatases; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Silencing; Hydrogen Peroxide; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocytes, Cardiac; RNA, Long Noncoding; Signal Transduction | 2021 |
Epigallocatechin-3-gallate exerts protective effect on epithelial function via PI3K/AKT signaling in thrombosis.
Topics: Animals; Apoptosis; Catechin; Interleukin-6; Interleukin-8; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Superoxide Dismutase; Thrombosis; Tumor Necrosis Factor-alpha | 2022 |
MicroRNA-384-5p/Beclin-1 As Potential Indicators For Epigallocatechin Gallate Against Cardiomyocytes Ischemia Reperfusion Injury By Inhibiting Autophagy Via PI3K/Akt Pathway.
Topics: Animals; Autophagy; Beclin-1; Catechin; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; HEK293 Cells; Humans; MicroRNAs; Molecular Structure; Myocardial Reperfusion Injury; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Structure-Activity Relationship | 2019 |
EGCG decreases myocardial infarction in both I/R and MIRI rats through reducing intracellular Ca2+ and increasing TnT levels in cardiomyocytes.
Topics: Animals; Apoptosis; Calcium; Catechin; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Troponin T | 2021 |
(-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions.
Topics: Animals; Apoptosis; Cardiotonic Agents; Catechin; Diabetes Mellitus, Experimental; Hyperglycemia; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Sirtuin 1; Superoxide Dismutase | 2017 |
Mitochondrial DNA‑induced inflammatory damage contributes to myocardial ischemia reperfusion injury in rats: Cardioprotective role of epigallocatechin.
Topics: Androstadienes; Animals; Catechin; Creatine Kinase; DNA, Mitochondrial; Enzyme-Linked Immunosorbent Assay; Interleukin-6; Interleukin-8; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Tumor Necrosis Factor-alpha; Wortmannin | 2017 |
Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts.
Topics: Animals; Apoptosis Inducing Factor; Blood Pressure; Catechin; Heart; Heart Ventricles; Hemodynamics; Hypoxia-Inducible Factor 1, alpha Subunit; Myocardial Contraction; Myocardial Reperfusion Injury; Perfusion; Rabbits; Staining and Labeling | 2018 |
EGCG protects cardiomyocytes against hypoxia-reperfusion injury through inhibition of OMA1 activation.
Topics: Animals; Catechin; Fibroblasts; Metalloproteases; Mice; Mitochondrial Proteins; Myocardial Reperfusion Injury; Myocytes, Cardiac | 2019 |
Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a/p53 axis.
Topics: Animals; Apoptosis; Cardiotonic Agents; Catechin; Cell Hypoxia; Cell Survival; Female; Male; Membrane Potential, Mitochondrial; MicroRNAs; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2019 |
Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats.
Topics: Animals; Camellia sinensis; Cardiotonic Agents; Catechin; Cell Death; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; MAP Kinase Signaling System; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley | 2014 |
Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux.
Topics: Animals; Apoptosis; Autophagy; Cardiotonic Agents; Catechin; Creatine Kinase, MB Form; Disease Models, Animal; Hemodynamics; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases | 2016 |
[Epigallocatechin-3-gallate Attenuates Myocardial Reperfusion Injury in Rats Through Activation of PI3K/Akt Signaling Pathway].
Topics: Animals; Catechin; Creatine Kinase; Interleukin-6; Interleukin-8; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation | 2016 |
Oral pretreatment with a green tea polyphenol for cardioprotection against ischemia-reperfusion injury in an isolated rat heart model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Animals; Antioxidants; Apoptosis; Blotting, Western; Camellia sinensis; Cardiotonic Agents; Caspase 3; Catechin; Deoxyguanosine; Dose-Response Relationship, Drug; Enzyme Activation; Immunohistochemistry; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Perfusion; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Preconditioning and acute effects of flavonoids in protecting cardiomyocytes from oxidative cell death.
Topics: Animals; Ascorbic Acid; Cardiotonic Agents; Catechin; Cell Death; Cell Line; Culture Media, Serum-Free; Cytoprotection; Flavonoids; Glucose; Glyceraldehyde-3-Phosphate Dehydrogenases; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidation-Reduction; Oxidative Stress; Oxygen; Quercetin; Rats; tert-Butylhydroperoxide; Time Factors | 2012 |
Protective effects of EGCg or GCg, a green tea catechin epimer, against postischemic myocardial dysfunction in guinea-pig hearts.
Topics: Animals; Antioxidants; Apoptosis; Calcium; Caspase 3; Catechin; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Female; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Perfusion; Reactive Oxygen Species | 2007 |
EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.
Topics: Animals; Blood Pressure; Catechin; Enalapril; Endothelium, Vascular; In Vitro Techniques; Insulin Resistance; Male; Mesenteric Veins; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WF; Tea; Vasodilator Agents | 2007 |